|
|
News Breaks
|
November 5, 2009
|
| 11:56 EDT |  | COV |
| theflyonthewall.com: | Nuvo Research to host a teleconference | | Nuvo Research hosted a teleconference to discuss FDA approval of Nuvo and Covidien's topical solution, Pennsaid, a non-steroidal anti-inflammatory drug (NSAID) used for treatment of the signs and symptoms of osteoarthritis of the knee. There will be a replay available starting November 5 at 11:30 am through November 12. :theflyonthewall.com |
|
|
News For COV From The Last 14 Days Check below for free stories on COV the last two weeks.
There are 5 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing. |
|
February 9, 2012
|
| 09:36 EDT | | COV |
|
|
February 8, 2012
|
| 23:32 EDT |  | COV |
|
|
February 3, 2012
|
| 07:39 EDT |  | COV |
|
|
February 2, 2012
|
| 14:05 EDT | | COV |
| theflyonthewall.com: | FDA and industry reach agreement in principle on medical device user fees | | The FDA and representatives from the medical device industry have reached an agreement in principle on proposed recommendations for the third reauthorization of a medical device user fee program. The recommendations would authorize the FDA to collect $595M in user fees over five years, plus adjustments for inflation. Details of the agreement, such as the fee structure, are expected to be finalized soon. :theflyonthewall.com |
|
|
February 1, 2012
|
| 16:28 EDT | | COV |
|
|
|
|
|
Subscribe for More Information